Wegovy sales surge, COVID vax sales sink, and ‘junk’ patents: Pharma news roundup

Novo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’…

Ozempic and 19 other drugs have ‘junk’ patents, the FTC says in a new challenge

The U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent…